We are live on
!
Find out more
CP
Corbenic Partners Portfolio holdings
AUM
$380M
1-Year Est. Return
10.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.51%
1 Year Est. Return
-10.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$30.8M
(+8.1%)
Cap. Flow
+$30M
Cap. Flow
% of AUM
7.28%
Top 10 Holdings %
Top 10 Hldgs %
67.78%
Holding
312
New
49
Increased
64
Reduced
28
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
+$5.61M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$4.92M |
| 3 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$3.82M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.22M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$288K |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$166K |
| 3 |
Alibaba
BABA
|
+$153K |
| 4 |
GREK
Global X MSCI Greece ETF
GREK
|
+$85K |
| 5 |
Procter & Gamble
PG
|
+$27.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.17% |
| 2 | Consumer Discretionary | 7.31% |
| 3 | Healthcare | 5.06% |
| 4 | Communication Services | 3.64% |
| 5 | Utilities | 3.35% |
Similar funds
MWM
BWM
FPS
IC
TF
RIM
PPW
HA
Corbenic Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Corbenic Partners held 312 positions worth $412M, up 8.1% from $382M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Corbenic Partners deployed $30M of net new capital in Q3 2021, opening 49 new positions and adding to 64 existing holdings. Its largest new stake was Moderna: 64 shares worth $25K.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $288K trimmed.
- Corbenic Partners's largest Q3 2021 buy was Moderna: 64 shares worth $25K.
- Corbenic Partners added most to iShares Core Dividend Growth ETF in Q3 2021, an estimated $5.61M increase.
- Corbenic Partners's biggest Q3 2021 reduction was Pfizer, cutting an estimated $288K.
- Corbenic Partners fully exited Global X MSCI Greece ETF in Q3 2021, selling an estimated $85K.
- Corbenic Partners's ten largest holdings make up 68% of its $412M portfolio in Q3 2021.
- Corbenic Partners opened 49 new positions and closed 22 in Q3 2021.
- Corbenic Partners's portfolio value rose 8.1% quarter-over-quarter to $412M.
Based on Corbenic Partners's 13F filing for Q3 2021, filed 13 Oct 2021.